Medtronic (NYSE:MDT – Get Rating) released its quarterly earnings data on Thursday. The medical technology company reported $1.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.56 by $0.01, RTT News reports. Medtronic had a net margin of 13.20% and a return on equity of 13.37%. The company had revenue of $8.54 billion during the quarter, compared to the consensus estimate of $8.25 billion. During the same quarter in the prior year, the firm posted $1.52 earnings per share. Medtronic’s revenue for the quarter was up 5.6% on a year-over-year basis. Medtronic updated its FY23 guidance to $5.00-5.10 EPS.
Medtronic Stock Performance
MDT stock opened at $87.49 on Thursday. The business’s 50-day moving average price is $84.69 and its two-hundred day moving average price is $82.10. The company has a current ratio of 1.76, a quick ratio of 1.39 and a debt-to-equity ratio of 0.43. The firm has a market cap of $116.40 billion, a PE ratio of 28.78, a P/E/G ratio of 2.10 and a beta of 0.71. Medtronic has a 1-year low of $75.76 and a 1-year high of $106.06.
Medtronic Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 14th. Shareholders of record on Friday, June 23rd will be issued a dividend of $0.69 per share. This is a positive change from Medtronic’s previous quarterly dividend of $0.68. This represents a $2.76 annualized dividend and a yield of 3.15%. Medtronic’s payout ratio is currently 89.47%.
Analyst Upgrades and Downgrades
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Bank of New York Mellon Corp lifted its holdings in shares of Medtronic by 33.1% in the third quarter. Bank of New York Mellon Corp now owns 19,374,686 shares of the medical technology company’s stock valued at $1,564,508,000 after purchasing an additional 4,816,172 shares in the last quarter. Moneta Group Investment Advisors LLC lifted its holdings in shares of Medtronic by 127,655.1% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 14,160,371 shares of the medical technology company’s stock valued at $1,100,544,000 after purchasing an additional 14,149,287 shares in the last quarter. Norges Bank bought a new stake in shares of Medtronic in the fourth quarter valued at about $1,062,316,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of Medtronic by 1.9% in the first quarter. Charles Schwab Investment Management Inc. now owns 6,801,196 shares of the medical technology company’s stock valued at $754,593,000 after purchasing an additional 128,661 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its holdings in shares of Medtronic by 95.3% in the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 2,836,806 shares of the medical technology company’s stock valued at $220,471,000 after purchasing an additional 1,384,136 shares in the last quarter. 80.37% of the stock is currently owned by institutional investors.
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit.
- Get a free copy of the StockNews.com research report on Medtronic (MDT)
- Upbeat Analysts Project Promising Prospects For Iridium Stock
- 2 Energy Mid-Caps Expected To Post Monster Earnings Growth
- Meet the Nasdaq’s 3 Biggest Dividend Payers
- Analog Devices Signals A Top For Semiconductor Stocks
- Pfizer Has the Prescription for Higher Share Prices
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.